Their study found that TFA-eluted peptide-loaded DC was more efficient to induce immune response specific to leukemia than CP-eluted peptide-loaded DC, suggesting that even the selection of the acid elution method to isolate cancer cell specific antigen peptides significantly affects to the immunogenic efficacy of generated ATCs. The gene discussed is CP; the disease is cancer.